The global “continuous renal replacement therapymarket”size is expected to gain momentum and reach USD 1,811.5 million by 2027 on account of the increasing prevalence of chronic diseases such as diabetes that leads to kidney issues. A published report by Fortune Business Insights titled, “Continuous Renal Replacement Therapy Market Size, Share & COVID-19 Impact Analysis, By Product Type (Systems, and Consumables), By Modality (Slow continuous ultrafiltration, Continuous Venovenous Hemofiltration, Continuous VenovenousHemodialysis, and Continuous Venovenous Hemodiafiltration, and Regional Forecast, 2020-2027,” states that the value of this market was USD 986.4 million in the year 2019 and will exhibit a CAGR of 8.0% between 2020 and 2027.
Drivers & Restraints-
Increasing Prevalence of Acute Kidney Injury to Propel Growth
Some of the factors promoting the continuous renal replacement therapy market growth include the increasing prevalence of chronic diseases such as diabetes, hypertension, and others that ultimately leads to kidney disorders. In addition to this, the rise in geriatric population and the increasing cases of acute kidney problems are likely to add impetus to the market in the coming years. Moreover, the rise in coronavirus positive cases mostly among the geriatric population and the rising rate of kidney cases among severely ill patients are likely to augment demand for continuous renal replacement therapy in the forthcoming years.
However, the stringent regulations imposed by the Food and Drug Administration on the approval of various products may pose a serious challenge to the market in the coming years. Nevertheless, the advent of medical technologies and rising investments in research and development of novel therapeutics are likely to create lucrative opportunities for the CRRT market in the coming years.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
North America is Dominating Market Owing to Rising Demand for Radical Innovation in Machines
In 2019, North America held the largest CRRT market share with a revenue of USD 354.3 million. This is attributable to the increasing demand for continuous renal replacement therapy and radical innovation in the machines. This, coupled with the increasing prevalence of kidney diseases especially in the U.S. Furthermore, the Asia Pacific market is expected to register fastest growth in the coming years owing to the rise in expenditure on the infrastructural development of healthcare sector in the developing nations.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245